DOI: 10.26655/JMCHEMSCI.2023.5.25 Abed-Mansoor A.F., Abu-Raghif A.R
Both contain the exact same active pharmaceutical ingredient: tirzepatide
If youve struggled with appetite control or difficulty losing weight despite your best efforts, GLP-1 therapy may fit your needs
Mood Disturbances and Depression: ALCAR's ability to restore neuronal energy metabolism and lipid function in the brain has been linked to antidepressant-like effects in animal models, suggesting potential support for emotional regulation
Both drugs use semaglutide, a GLP-1 RA, and are manufactured by Novo Nordisk
Additionally, their under-development triple agonist, Retatrutide, has shown unprecedented weight loss effects in phase 2 clinical trials.16 Matthias Tschp and his team discovered that dual agonists targeting both GLP-1 and GIP receptors (GIPR) are more effective in treating diabetes than those targeting only GLP-1R